
A potent broad-spectrum, third-generation cephalosporin (CAS 64486-18-6) known for its excellent CNS penetration and beta-lactamase stability.
In the demanding field of injectable drug production, the molecular purity of Cefotaxime sodium directly influences patient outcomes. For instance, its rapid onset of action makes it a first-line therapy for intensive care units. Consequently, pharmaceutical plants prioritize our API for its consistent solubility and neutral pH during reconstitution. As a result, Zyntex ensures that every batch undergoes rigorous sterility testing and particle size optimization to prevent complications during intravenous or intramuscular administration.
Moreover, the metabolic stability of Cefotaxime sodium undoubtedly drives its preference in pediatric and geriatric care. Its unique pharmacokinetic profile allows for effective management of complicated intra-abdominal infections. At the same time, Zyntex maintains a strictly monitored supply chain to ensure that the API remains free from oxidative degradation. In short, our high-purity product serves as a vital resource for global healthcare systems combating resistant bacterial strains through reliable, high-integrity pharmaceutical manufacturing.
Recently, there has been an increased focus on the stability of beta-lactam antibiotics in diverse environmental conditions. Because of this, Zyntex utilizes specialized moisture-resistant packaging for Cefotaxime sodium to preserve its bactericidal potency. Ultimately, by choosing Zyntex, manufacturers align themselves with the highest international quality benchmarks. To conclude, our commitment to excellence ensures that your final parenteral products deliver consistent life-saving performance.
This sterile-grade API is specifically vital in the following four sectors:
ICU protocols; thus enabling the treatment of systemic bacterial sepsis and meningitis.
Neonatal care; consequently essential for managing neonatal infections with high safety margins.
Prophylaxis; undoubtedly vital for preventing infections during and after major surgical procedures.
Injectable R&D; specifically assisting in the development of high-stability parenteral dosage forms.
| Parameter | Standard Value |
|---|---|
| Product Name | Cefotaxime Sodium |
| CAS Number | 64486-18-6 |
| Molecular Formula | C16H16N5NaO7S2 |
| Solubility | Freely soluble in water |
⚠️ Safety Warning: Cefotaxime sodium is a potent medicinal compound for professional pharmaceutical use. It must be administered under strict medical supervision. Hypersensitivity reactions may occur in patients allergic to penicillins or cephalosporins.